Keros Therapeutics Inc. (KROS)
NASDAQ: KROS
· Real-Time Price · USD
13.45
0.04 (0.30%)
At close: Jul 03, 2025, 2:59 PM
13.12
-2.45%
After-hours: Jul 03, 2025, 02:59 PM EDT
0.30% (1D)
| Bid | 12.25 |
| Market Cap | 546.28M |
| Revenue (ttm) | 214.71M |
| Net Income (ttm) | 4.21M |
| EPS (ttm) | -0.17 |
| PE Ratio (ttm) | -79.12 |
| Forward PE | -3.16 |
| Analyst | Hold |
| Ask | 13.99 |
| Volume | 146,219 |
| Avg. Volume (20D) | 932,142 |
| Open | 13.43 |
| Previous Close | 13.41 |
| Day's Range | 13.38 - 13.69 |
| 52-Week Range | 9.12 - 72.37 |
| Beta | 1.29 |
About KROS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KROS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KROS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Keros Therapeutics Inc. is scheduled to release its earnings on Aug 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+18.49%
Keros Therapeutics shares are trading higher. The ...
Unlock content with
Pro Subscription
5 months ago
-16.51%
Keros Therapeutics shares are trading lower after the company announced an update on its Phase 2 TROPOS trial and halted all dosing based on the ongoing safety review.
1 month ago · https://thefly.com
BofA says Keros cost reduction 'disappoints,' still sees reasons to like story04 Jun
